Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine and Creatine Monohydrate in DMD
NCT00018109Phase 3Completed
- Sponsor
- National Center for Research Resources
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Glutamine, Creatine Monohydrate and Placebo (3 arms). Primary endpoints: Percentage change in average muscle strength score at 6 months and Quantitative Muscle Testing performance at 6 months. Status: completed.
02
Drugs
glutaminecreatine
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT00018109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018109.